CDO1 and renal carcinoma: In recent years, with the deepening of epigenetic research, the epigenetic regulatory mechanisms of renal cancer, especially DNA methylation, are often used to predict the survival time of renal cancer, including DAB2IP [30], RCVRN [31], CRHBP [32], AR [33], and CDO1 [34].